Vanda Pharmaceuticals (VNDA)

SUMMARY

BULLS

BEARS

DATA CENTRAL

Day
52 Wk

Steven Cohen's SAC Capital Files 13G on Vanda Pharma (VNDA)

market folly Jun 10

In a 13G filed recently with the SEC, hedge fund SAC Capital has disclosed an 8.6% ownership stake in Vanda Pharmaceuticals (VNDA) . They now own 2,279,423 shares. You may be familiar with this stock as it has recently surged huge after their...

Vanda Ripe for Picking, or Dead on the Vine?

TheStreet.com Jun 8

A bull and a bear make their cases for whether a larger drug company will buy Vanda Pharmaceuticals.

Hemispherx's CFS Drug Is a Long Shot

TheStreet.com May 28

Too many red flags are flying over Hemispherx's chronic fatigue syndrome drug to be confident the FDA will approve it.

It's Approved! Now Back to Work

Motley Fool May 27

Bristol-Myers breathes a sigh of relief.

10 Stocks to Shake the Market

Motley Fool May 21

These companies have made big gains in the past month.

Is There Life After 600% Returns?

Motley Fool May 18

Don't ignore companies just because they've been on a tear.

Biotech Stock Mailbag: Sequenom, Vanda

TheStreet.com May 15

Readers want to know what's next for Sequenom after the data mishandling debacle, and what the prognosis is for Vanda.

Vanda, Up 800%, Still Has Room to Rise

TheStreet.com May 11

Vanda is up 800% after the FDA approved its schizophrenia drug Fanapt, but investors still may find reason to buy the stock.

Is The FDA Easing Up?

Forbes May 8

How one company turned a rejection into a thumbs up, and what it could mean for the drug industry as a whole.

Stock Search: Vanda Wins

TheStreet.com May 7

Vanda Wins. Alix Steel details the top 10 most searched stocks on thestreet.com.

Suggest other news sources for this topic


	Suggest a News Source Topic Top news source/blog that we're missing Why do you recommend this news source? Close Thanks for your suggestion!

The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.

You may also be interested in articles related to Vanda Pharmaceuticals (VNDA):

Antipsychotic Drug Market

[edit] References

Retrieved from "http://www.wikinvest.com/stock/Vanda_Pharmaceuticals_(VNDA)"

Categories: Pharma & Healthcare | Biotechnology

Worried about pump and dump?

We review changes
for stock spam

» read more

Want to make Wikinvest better?

We need your help,
contribute today

» learn how

Do you write software?

We are recruiting
the best engineers

» view jobs

Like Wikinvest?

Spread the word —
Tell your friends!

» spread the word

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.